SCHEMBL4936081

SCHEMBL4936081

CC(C)CN[C@H]1CCCc2cccnc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
CXCR4 P61073 8/20 0.44
ADORA2A P29274 1/20 0.40
CYP2D6 P10635 2/20 0.40
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADRB3 P13945 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC40A1 Q9NP59 1/20 0.38
SCN1A P35498 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN8A Q9UQD0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4562781 1.00 HDAC1 (0.54) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4885407 0.85 HDAC1 (0.56) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4885421 0.85 HDAC1 (0.56) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4113740 0.84 HDAC1 (0.48) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4882672 0.84 HDAC1 (0.48) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL3736077 0.83 HDAC1 (0.54) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4889228 0.83 HDAC1 (0.54) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL4123198 0.83 HDAC1 (0.54) HDAC1HDAC6CXCR4ADORA2ACYP2D6
SCHEMBL13909820 0.81 HDAC1 (0.76) HDAC1HDAC6CXCR4CYP2D6CYP3A4
SCHEMBL30379489 0.81 HDAC1 (0.61) HDAC1HDAC6CXCR4ADORA2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096861-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION (US) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096861-A1 Chemical Compounds CCR5, CXCR4, CXCR3 HDAC1 844/4885HDAC6 568/4885CXCR4 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.